Positive early stage data for Verve Therapeutics Inc.’s base editing therapy points to a range of development options, ...

Edwards Lifesciences Corp.’s Sapien M3 secured CE mark for its Sapien M3 mitral valve replacement system for transfemoral treatment of patients with mitral valve disease who are ineligible for surgery ...

Researchers have developed a new compound that can prevent long COVID symptoms in mice that could lead to a future drug for ...

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing Manage cookie preferences ...